Kris Natarajan

Business Development Lead at Verily Life Sciences
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Seattle Area

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Business Development Lead
      • Mar 2020 - Present

      San Francisco Bay Area Formerly known as Google Life Sciences

    • Switzerland
    • International Affairs
    • 700 & Above Employee
    • Expert Advisor
      • Nov 2017 - Present

      Geneva Area, Switzerland Technical assistance, training, laboratory testing and assessment of medical products — Essential medicines and health products (EMP) Department

    • United States
    • Research Services
    • 1 - 100 Employee
    • Life Sciences Partnerships Lead (New Horizons Team)
      • May 2013 - Mar 2020

      Greater Seattle Area GH Labs is a nonprofit organization created in 2020 by Gates Ventures (the private office of Bill Gates) and the Bill and Melinda Gates Foundation. We build tools and technologies to address unmet needs in primary healthcare centers and last-mile service delivery in low- and middle-income countries (LMICs) around the world.

    • Non-profit Organizations
    • 1 - 100 Employee
    • Senior Technical Advisor to the CEO
      • 2012 - 2013

      Ibadan, Nigeria and London, United Kingdom Advised CHESTRAD, host of Global Health South, on the design, implementation and analysis of its Southern Civil Society e-consultation supported by the Health Theme of the Post-2015 Development Agenda, co-convened by WHO and UNICEF with support from the Governments of Botswana and Sweden. Provided strategic counsel on the design, development and launch of the Nigerian Vaccine Access Programme, a country-led public-private partnership increasing access -- equitably and sustainably -- to… Show more Advised CHESTRAD, host of Global Health South, on the design, implementation and analysis of its Southern Civil Society e-consultation supported by the Health Theme of the Post-2015 Development Agenda, co-convened by WHO and UNICEF with support from the Governments of Botswana and Sweden. Provided strategic counsel on the design, development and launch of the Nigerian Vaccine Access Programme, a country-led public-private partnership increasing access -- equitably and sustainably -- to new and routine vaccines prioritized by the National Primary Health Care Development Agency. Led technical facilitation and resource mobilization for the 2nd Retreat and Dialogue of the Alliance of Southern Civil Society in Global Health summit in Accra. The 2nd Retreat and Dialogue -- convened by CHESTRAD and UNFPA and co-sponsored by the Governments of Nigeria and Ghana -- assembled key international stakeholders (civil society organizations, parliamentarians, Ministries of Health, UN bodies, IHP+, PMNCH, GAVI Alliance, Decade of Vaccines Collaboration, World Bank, international development partners and industry) to review initiatives, progress and strategic opportunities for capacity enabling, institutional strengthening, advocacy and accountability for Southern Civil Society. Show less

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Director, Global Health Partnerships and Global Vaccine Initiatives
      • 2008 - 2011

      Whitehouse Station, NJ and West Point, PA Administered US$155 million portfolio of vaccine access and capacity enabling initiatives creating shared value in low- and middle-income countries spanning EMEA, Latin America and Caribbean, Asia Pacific and CIS regions. Implemented public-private partnerships with Ministries of Health, Education and Finance; civil society organizations; faith-based institutions; academia; WHO and UNICEF; bilateral aid agencies; international development partners; philanthropic foundations; and private sector… Show more Administered US$155 million portfolio of vaccine access and capacity enabling initiatives creating shared value in low- and middle-income countries spanning EMEA, Latin America and Caribbean, Asia Pacific and CIS regions. Implemented public-private partnerships with Ministries of Health, Education and Finance; civil society organizations; faith-based institutions; academia; WHO and UNICEF; bilateral aid agencies; international development partners; philanthropic foundations; and private sector entities. Provided consultative feedback to the United Nations Global Compact, UNICEF and Save the Children during their drafting of the Children’s Rights and Business Principles (2012), the first comprehensive set of principles guiding companies on the full range of actions that they can take in the workplace, marketplace and community to respect and support children’s rights. Oversaw GARDASIL Access Program operations, policy and communications functions, including monitoring and evaluation (M&E) and evidence-based advocacy for the feasibility and sustainability of cervical cancer vaccination in low and middle income countries. FOCAL AREAS: ► RMNCH+A ► Children's Rights ► Human Resources for Health (HRH) Leadership Training ► Vaccine Management and Immunization Services Training (Kenya, Mali, Uganda, Zambia) ► Integrated Disease Surveillance and Response (IDSR) ► Social and Community Mobilization ► Information, Education and Communication (IEC) Strategies ► Measles Vaccination Campaigns advanced by the Measles and Rubella Initiative (Nigeria and India) ► HPV Vaccination Pilots (Bhutan, Bolivia, Cambodia, Cameroon, Georgia, Ghana, Guyana, Haiti, Honduras, Kenya, Kiribati, Lesotho, Mali, Moldova, Mongolia, Nepal, Nigeria, Tanzania, Uganda, Uzbekistan) ► HPV Vaccine National Public Sector Introduction (Lesotho) ► Pneumococcal Vaccine National Public Sector Introductions (Nicaragua and Honduras)

    • Manager, International Medical Affairs and Health Policy
      • 2006 - 2008

      West Point, PA Managed internal and external processes to secure WHO prequalification of Merck’s HPV, Rotavirus and MMR vaccines, thereby improving global market access via United Nations procurement channels. Implemented and expanded the Merck Vaccine Network – Africa (MVN-A), a philanthropic vaccine management training initiative endorsed by the GAVI Alliance to help improve immunization program capacity in Kenya, Mali, Uganda and Zambia. Promoted knowledge sharing across all four countries… Show more Managed internal and external processes to secure WHO prequalification of Merck’s HPV, Rotavirus and MMR vaccines, thereby improving global market access via United Nations procurement channels. Implemented and expanded the Merck Vaccine Network – Africa (MVN-A), a philanthropic vaccine management training initiative endorsed by the GAVI Alliance to help improve immunization program capacity in Kenya, Mali, Uganda and Zambia. Promoted knowledge sharing across all four countries, collaborating with Ministries of Health and Education, civil society organizations, WHO and UNICEF amidst their training activities for supplemental immunization activities and new vaccine introductions (Polio, Measles, Pentavalent, Meningococcal A conjugate, Pneumococcal conjugate, Rotavirus).

    • Graduate Practicum, Economic Development and Pricing Strategy, Europe and Asia
      • 2005 - 2006

      Boston, MA Developed strategic justification for corporate re-entry in India by negotiating 5-year commitments (franchise revenues; manufacturing, procurement and R&D synergies; and resulting operating income targets) amongst cross-divisional global P&L owners. Constructed deterministic models of public versus private drug expenditures amidst price regulation legislation proposed in Belgium, Bulgaria, Czech Republic, Hungary, Ireland, Latvia, Slovenia and South Korea – advised Merck/MSD subsidiary… Show more Developed strategic justification for corporate re-entry in India by negotiating 5-year commitments (franchise revenues; manufacturing, procurement and R&D synergies; and resulting operating income targets) amongst cross-divisional global P&L owners. Constructed deterministic models of public versus private drug expenditures amidst price regulation legislation proposed in Belgium, Bulgaria, Czech Republic, Hungary, Ireland, Latvia, Slovenia and South Korea – advised Merck/MSD subsidiary Managing Directors in advance of formal policy engagements with Ministries of Finance and Health.

    • Switzerland
    • International Affairs
    • 700 & Above Employee
    • Postgraduate Intern, Office of the Assistant Director-General
      • Dec 2005 - Jan 2006

      Geneva, Switzerland (Former) Assistant Director-General Dr. Tim Evans

    • Postgraduate Intern, Head Office (Imperial College School of Medicine)
      • Dec 2004 - Jan 2005

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Manager, Business Development
      • 2001 - 2004

      Horsham, PA Devised and executed European commercial expansion of VC-backed startup's proprietary suite of online pharmaceutical primary marketing research services. Directed internal operations and managed external alliances to launch multi-country quantitative and qualitative studies targeting physicians in the US, UK, France, Germany, Italy and Spain. Conducted market assessments, addressed product development needs, localized country websites, negotiated term sheets with ex-US prospects, executed… Show more Devised and executed European commercial expansion of VC-backed startup's proprietary suite of online pharmaceutical primary marketing research services. Directed internal operations and managed external alliances to launch multi-country quantitative and qualitative studies targeting physicians in the US, UK, France, Germany, Italy and Spain. Conducted market assessments, addressed product development needs, localized country websites, negotiated term sheets with ex-US prospects, executed strategic partnership agreements, and ensured compliance with all EU Directives governing commercial transactions, data privacy and IP.

    • Analyst, Marketing and Sales Operations
      • 2000 - 2001

      Horsham, PA

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Financial Analyst, Global Financial Information Services (GFIS)
      • 1999 - 2000

      Whitehouse Station, NJ

    • Analyst, Manufacturing Management Development Program (MMDP)
      • 1997 - 1999

      Rahway, NJ and Whitehouse Station, NJ Rotational assignments: - Validation and Operations Improvement - Merck Manufacturing Division Financial Services - Environmental and Regulatory Affairs - Global and Site Procurement - Maintenance, Repair and Operations (MRO)

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Intern, Operations Improvement, Bacterial Vaccines Manufacturing
      • Jun 1996 - Aug 1996

      West Point, PA

Education

  • Harvard University
    Master of Science, Health Policy and Management
  • Cornell University
    Bachelor of Science, Operations Research and Industrial Engineering

Community

You need to have a working account to view this content. Click here to join now